|
|
| Line 1: |
Line 1: |
| [[Image:1wt7.gif|left|200px]] | | {{Seed}} |
| | [[Image:1wt7.png|left|200px]] |
|
| |
|
| <!-- | | <!-- |
| Line 9: |
Line 10: |
| {{STRUCTURE_1wt7| PDB=1wt7 | SCENE= }} | | {{STRUCTURE_1wt7| PDB=1wt7 | SCENE= }} |
|
| |
|
| '''Solution structure of BuTX-MTX: a butantoxin-maurotoxin chimera'''
| | ===Solution structure of BuTX-MTX: a butantoxin-maurotoxin chimera=== |
|
| |
|
|
| |
|
| ==Overview==
| | <!-- |
| Scorpion toxins interact with their target ion channels through multiple molecular contacts. Because a "gain of function" approach has never been described to evaluate the importance of the molecular contacts in defining toxin affinity, we experimentally examined whether increasing the molecular contacts between a toxin and an ion channel directly impacts toxin affinity. For this purpose, we focused on two scorpion peptides, the well-characterized maurotoxin with its variant Pi1-like disulfide bridging (MTX(Pi1)), used as a molecular template, and butantoxin (BuTX), used as an N-terminal domain provider. BuTX is found to be 60-fold less potent than MTX(Pi1) in blocking Kv1.2 (IC(50) values of 165 nM for BuTX versus 2.8 nM for MTX(Pi1)). Removal of its N-terminal domain (nine residues) further decreases BuTX affinity for Kv1.2 by 5.6-fold, which is in agreement with docking simulation data showing the importance of this domain in BuTX-Kv1.2 interaction. Transfer of the BuTX N-terminal domain to MTX(Pi1) results in a chimera with five disulfide bridges (BuTX-MTX(Pi1)) that exhibits 22-fold greater affinity for Kv1.2 than MTX(Pi1) itself, in spite of the lower affinity of BuTX as compared to MTX(Pi1). Docking experiments performed with the 3-D structure of BuTX-MTX(Pi1) in solution, as solved by (1)H-NMR, reveal that the N-terminal domain of BuTX participates in the increased affinity for Kv1.2 through additional molecular contacts. Altogether, the data indicate that acting on molecular contacts between a toxin and a channel is an efficient strategy to modulate toxin affinity.
| | The line below this paragraph, {{ABSTRACT_PUBMED_15971207}}, adds the Publication Abstract to the page |
| | (as it appears on PubMed at http://www.pubmed.gov), where 15971207 is the PubMed ID number. |
| | --> |
| | {{ABSTRACT_PUBMED_15971207}} |
|
| |
|
| ==About this Structure== | | ==About this Structure== |
| 1WT7 is a [[Single protein]] structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1WT7 OCA]. | | 1WT7 is a [[Single protein]] structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1WT7 OCA]. |
|
| |
|
| ==Reference== | | ==Reference== |
| Line 40: |
Line 44: |
| [[Category: Scorpion toxin]] | | [[Category: Scorpion toxin]] |
| [[Category: Toxin affinity]] | | [[Category: Toxin affinity]] |
| ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 14:06:23 2008'' | | |
| | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 03:05:53 2008'' |